These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 37847100

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cellular and Humoral Immunogenicity Investigation of Single and Repeated Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering From Tendon Injuries.
    Depuydt E, Broeckx SY, Chiers K, Patruno M, Da Dalt L, Duchateau L, Saunders J, Pille F, Martens A, Van Hecke L, Spaas JH.
    Front Vet Sci; 2021; 8():789293. PubMed ID: 35281431
    [Abstract] [Full Text] [Related]

  • 5. Clinical follow-up of horses treated with allogeneic equine mesenchymal stem cells derived from umbilical cord blood for different tendon and ligament disorders.
    Van Loon VJ, Scheffer CJ, Genn HJ, Hoogendoorn AC, Greve JW.
    Vet Q; 2014; 34(2):92-7. PubMed ID: 25072527
    [Abstract] [Full Text] [Related]

  • 6. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.
    Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK.
    Equine Vet J; 2012 Jan; 44(1):25-32. PubMed ID: 21615465
    [Abstract] [Full Text] [Related]

  • 7. The effect of intralesional injection of bone marrow derived mesenchymal stem cells and bone marrow supernatant on collagen fibril size in a surgical model of equine superficial digital flexor tendonitis.
    Caniglia CJ, Schramme MC, Smith RK.
    Equine Vet J; 2012 Sep; 44(5):587-93. PubMed ID: 22150794
    [Abstract] [Full Text] [Related]

  • 8. Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses.
    Beerts C, Suls M, Broeckx SY, Seys B, Vandenberghe A, Declercq J, Duchateau L, Vidal MA, Spaas JH.
    Front Vet Sci; 2017 Sep; 4():158. PubMed ID: 29018808
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessing the functional properties of tenogenic primed mesenchymal stem cells in ex vivo equine tendon and ligament explants: A preliminary study.
    Depuydt E, Chiers K, Van Hecke L, Saunders J, Martens A, Pille F, Spaas JH.
    Stem Cell Res; 2022 Dec; 65():102963. PubMed ID: 36395687
    [Abstract] [Full Text] [Related]

  • 13. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.
    Lange-Consiglio A, Tassan S, Corradetti B, Meucci A, Perego R, Bizzaro D, Cremonesi F.
    Cytotherapy; 2013 Aug; 15(8):1011-20. PubMed ID: 23602577
    [Abstract] [Full Text] [Related]

  • 14. Effect of single intralesional treatment of surgically induced equine superficial digital flexor tendon core lesions with adipose-derived mesenchymal stromal cells: a controlled experimental trial.
    Geburek F, Roggel F, van Schie HTM, Beineke A, Estrada R, Weber K, Hellige M, Rohn K, Jagodzinski M, Welke B, Hurschler C, Conrad S, Skutella T, van de Lest C, van Weeren R, Stadler PM.
    Stem Cell Res Ther; 2017 Jun 05; 8(1):129. PubMed ID: 28583184
    [Abstract] [Full Text] [Related]

  • 15. Outcome after lacerations of the superficial and deep digital flexor tendons, suspensory ligament and/or distal sesamoidean ligaments in 106 horses.
    Jordana M, Wilderjans H, Boswell J, Dewulf J, Smith RK, Martens A.
    Vet Surg; 2011 Apr 05; 40(3):277-83. PubMed ID: 21361993
    [Abstract] [Full Text] [Related]

  • 16. Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb.
    Sole A, Spriet M, Padgett KA, Vaughan B, Galuppo LD, Borjesson DL, Wisner ER, Vidal MA.
    Equine Vet J; 2013 Nov 05; 45(6):726-31. PubMed ID: 23574488
    [Abstract] [Full Text] [Related]

  • 17. Comparison of autologous bone marrow and adipose tissue derived mesenchymal stem cells, and platelet rich plasma, for treating surgically induced lesions of the equine superficial digital flexor tendon.
    Romero A, Barrachina L, Ranera B, Remacha AR, Moreno B, de Blas I, Sanz A, Vázquez FJ, Vitoria A, Junquera C, Zaragoza P, Rodellar C.
    Vet J; 2017 Jun 05; 224():76-84. PubMed ID: 28697880
    [Abstract] [Full Text] [Related]

  • 18. Allogeneic adipose tissue-derived mesenchymal stem cells in combination with platelet rich plasma are safe and effective in the therapy of superficial digital flexor tendonitis in the horse.
    Ricco S, Renzi S, Del Bue M, Conti V, Merli E, Ramoni R, Lucarelli E, Gnudi G, Ferrari M, Grolli S.
    Int J Immunopathol Pharmacol; 2013 Jun 05; 26(1 Suppl):61-8. PubMed ID: 24046950
    [Abstract] [Full Text] [Related]

  • 19. The use of sonoelastography to assess the recovery of stiffness after equine superficial digital flexor tendon injuries: A preliminary prospective longitudinal study of the healing process.
    Tamura N, Nukada T, Kato T, Kuroda T, Kotoyori Y, Fukuda K, Kasashima Y.
    Equine Vet J; 2017 Sep 05; 49(5):590-595. PubMed ID: 28083881
    [Abstract] [Full Text] [Related]

  • 20. Gene Therapy Using Plasmid DNA Encoding VEGF164 and FGF2 Genes: A Novel Treatment of Naturally Occurring Tendinitis and Desmitis in Horses.
    Kovac M, Litvin YA, Aliev RO, Zakirova EY, Rutland CS, Kiyasov AP, Rizvanov AA.
    Front Pharmacol; 2018 Sep 05; 9():978. PubMed ID: 30233367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.